These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16519244)

  • 1. New drugs for HIV therapy.
    Rockstroh JK
    J HIV Ther; 2005 Dec; 10(4):66-7. PubMed ID: 16519244
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Merck integrase inhibitor.
    TreatmentUpdate; 2006; 18(4):3-4. PubMed ID: 17205652
    [No Abstract]   [Full Text] [Related]  

  • 3. Tribulations and trials in HIV disease, Part 2.
    Boyle BA
    AIDS Read; 2006 Jun; 16(6):291-4. PubMed ID: 16795918
    [No Abstract]   [Full Text] [Related]  

  • 4. [A clinical study with an HIV integrase inhibitor].
    Winckler T
    Pharm Unserer Zeit; 2007; 36(4):251-2. PubMed ID: 17623312
    [No Abstract]   [Full Text] [Related]  

  • 5. [Raltegravir an integrase inhibitor--a great leap forward within reach].
    Med Monatsschr Pharm; 2007 Nov; 30(11):419-21. PubMed ID: 18062335
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.
    TreatmentUpdate; 2007 Feb; 19(2):8-9. PubMed ID: 17447316
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. Raltegravir--other issues.
    TreatmentUpdate; 2007 Feb; 19(2):9-10. PubMed ID: 17447317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 9. Raltegravir, a new HIV integrase inhibitor.
    Gandhi RT
    AIDS Clin Care; 2007 Dec; 19(12):105. PubMed ID: 18399003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV integrase inhibitors--out of the pipeline and into the clinic.
    Havlir DV
    N Engl J Med; 2008 Jul; 359(4):416-8. PubMed ID: 18650518
    [No Abstract]   [Full Text] [Related]  

  • 11. Two new drugs for HIV infection.
    Med Lett Drugs Ther; 2008 Jan; 50(1277):2-4. PubMed ID: 18197163
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Merck's integrase inhibitor--short-term efficacy.
    TreatmentUpdate; 2006; 18(5):2-3. PubMed ID: 17205646
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrase inhibitor MK-0518: Merck opens expanded-access program.
    James JS
    AIDS Treat News; 2006; (419):5. PubMed ID: 17096488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV agents. Raltegravir (Isentress)--results after one year.
    TreatmentUpdate; 2007; 19(6):8-9. PubMed ID: 18041152
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-HIV agents. Some drug interactions with Merck's integrase inhibitor.
    TreatmentUpdate; 2006; 18(5):3. PubMed ID: 17205647
    [No Abstract]   [Full Text] [Related]  

  • 16. 13th annual HIV drug guide.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):28-55. PubMed ID: 19280745
    [No Abstract]   [Full Text] [Related]  

  • 17. 12th annual HIV drug guide.
    Diaz-Linares M; Vázquez E; Gallant J; Delaney M
    Posit Aware; 2008; 19(1):19-48. PubMed ID: 18546577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raltegravir as first integrase inhibitor in an HIV-infection].
    Papendorp SG; Brinkman K
    Ned Tijdschr Geneeskd; 2009 Jan; 153(5):166-7. PubMed ID: 19256240
    [No Abstract]   [Full Text] [Related]  

  • 19. XVI International AIDS Conference: Part 2.
    Boyle BA; Cohen CJ; Moyle GJ; Elion R; Sax PE; Frank I
    AIDS Read; 2006 Nov; 16(11):581-4, 591-2. PubMed ID: 17152645
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV treatment and the nonclinician: getting your bearings.
    HRSA Careaction; 2007 Jan; ():1-12. PubMed ID: 17380596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.